Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reported 14 cases of frontal edema following mesotherapy for androgenetic alopecia, suggesting clinicians should be aware of this potential side effect.

This review highlights current and future AI applications in hair restoration and diagnosis of hair disorders, including automated systems for hair detection and self-diagnosis, emphasizing the need for experts to understand their benefits and limitations.

This study reports a case of Ellis van Creveld syndrome in a 40-year-old Iranian woman, highlighting uncommon features such as pectus excavatum, Phrygian cap gallbladder, liver hemangioma, polycystic ovarian disease, and breast fibrocystic cysts.

In this study, a topical lotion containing Redensyl and Sepicontrol A5 demonstrated effectiveness for treating androgenetic alopecia over 24 weeks, with 73.1% of users seeing moderate improvement and notable increases in hair cycle ratios, alongside enhanced quality of life and satisfaction.

Poor sleep, meat-heavy diets, and junk food worsen hair loss, while sugary drinks may help.

Hair enzyme activity predicts minoxidil success in Brazilian women with hair loss.

This review explores the clinical characteristics, risk factors, and treatment challenges of scalp basal cell carcinoma, noting its potential aggressiveness and difficulty in treatment, but reports no new clinical results.

Topical tretinoin may increase beard hair density.

This study reported that using non-absorbable magnesium microneedle patches for 12 weeks improved under-eye wrinkles as measured by a grading scale and wrinkle index, with minimal discomfort and no significant change in dermal thickness.

This study demonstrated that PRP treatment improved hair metrics in androgenetic alopecia, with the dermapen method proving more effective than the point-by-point technique for specific hair growth indicators.

In this case report, a 28-year-old male with alopecia areata experienced successful hair growth following follicular unit extraction (FUE), with no recurrence observed over a 1-year follow-up.

This study found that intralesional triamcinolone acetonide was more effective than saline for hair regrowth in scalp alopecia areata, with 10 mg/mL showing the best response but more side effects.

This article is a letter to the editor about attempts to target microinflammation in androgenetic alopecia and includes no new clinical results.

This article addresses the mechanisms of androgenic alopecia and seeks to clarify misconceptions, but it reports no new empirical findings and calls for further controlled studies.

This study reported that the Biofibre® hair implantation system, used on 1,518 patients with various degrees of baldness and causes of alopecia, delivered immediate and visible results without scarring or hospitalization, which greatly improved patients' self-esteem and psychological well-being.

This letter discusses the use of UVA-1 in the treatment of alopecia areata but reports no new clinical results.

In this study, Deplanque et al. (2016) explored doxycycline's role in preventing erlotinib-induced folliculitis in patients with non-small-cell lung cancer, highlighting skin toxicity as a common side effect that can affect patient adherence to treatment.

Using minoxidil and tretinoin on the skin, along with oral vitamin D, improved hair thickness and density in two girls with woolly hair.

In this study, combining treatment for acne and sensitive skin improved clinical outcomes and skin physiological function more significantly than treating acne alone in patients with acne and sensitive skin.

This study found that intradermal injections of autologous cell-free fat extract significantly improved the condition of postinflammatory hyperpigmentation patients, with high patient satisfaction and minimal adverse effects.

Results are not reported in this article by Zizhuo Li et al. on baricitinib as a treatment for lichen planopilaris.

In this study, tofacitinib showed a mixed response in treating refractory alopecia areata, with some patients experiencing complete or partial hair regrowth and others showing no response, particularly those with alopecia universalis.

This case series reports promising initial data on using microneedling with a dermaroller in trichotillomania patients, indicating potential efficacy in reducing compulsive hair-pulling behaviors and promoting hair regrowth.

This study concluded that both botulinum toxin A and multivitamins mesotherapy effectively treat telogen effluvium, but a single botulinum toxin A session may be preferable due to its convenience and comparable efficacy.

This study found that using topical latanoprost 0.005% solution significantly increased hair density and regrowth in patients with scalp alopecia areata over 12 weeks, although it did not significantly reduce hair loss area compared to the placebo.

Natural products like saw palmetto, caffeine, melatonin, marine extracts, rosemary oil, procyanidin, pumpkin seed oil, and cannabidiol oil could potentially treat male hair loss.

This case study reports a 58-year-old woman experiencing pressure-induced alopecia with concomitant acute telogen effluvium after severe COVID-19, suggesting a potential link between prolonged hospitalization and hair loss.

This study found that low-level laser therapy significantly increased hair counts in women with female pattern hair loss but not in those with telogen effluvium, without serious adverse events.

This study found that a topical herbal solution significantly increased hair diameter and density in men with androgenetic alopecia compared to minoxidil after 36 weeks of treatment.

This analysis from Egyptian researchers identified common risk factors associated with chronic telogen effluvium in children, but it reports no new clinical results.